Annual Revenue Growth (Last Twelve Months): SciSparc Corp (SPRC)

Graphic logo of SciSparc Ltd (SPRC)

SciSparc Ltd management is focusing on cost optimization and maintaining margins within a micro-cap environment. The revenue trend over four quarters year-over-year demonstrates business dynamics where the current parameter equals -26.80. The company's scientific authority is based on innovations in CNS therapy, while stable demand for autism treatment ensures development remains independent of economic crises.

SPRC Clearmind Medicine Sales Growth YoY (TTM) (11/23/2025 - 11/18/2026)

Summary analytical data breakdowns for SciSparc Ltd (SPRC)

- market value and analyst target forecast:
- company stock exchange capitalization indicators:
Summary company analytics:SPRC (SciSparc Corp)
Signature product of SciSparc Corp

This indicator measures the revenue growth rate over a rolling year, smoothing out short-term fluctuations to identify the actual consumer demand trend and eliminate inflationary distortions. By analyzing the current TTM sales dynamics of SciSparc Ltd (SPRC), an investor can assess how the commercialization of patents and the success of clinical trials for dementia drugs translate into real financial business growth.